SEC Form D · Amendment · filed May 18, 2022
Artax Biopharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Alan E. Walts · Cambridge, MADirectorRobert M. Armstrong, Ph.D · Cambridge, MADirectorRaj W. Parekh · Cambridge, MADirectorDamia M. Tormo, Ph.D · Cambridge, MADirectorGino M. Santini · Cambridge, MADirectorCasper W. Breum · Cambridge, MADirectorJoseph M. Lobacki · Cambridge, MAExec · DirectorQuentin Yarie · Toronto, Ontario, CanadaDirectorScott Stout · El Segundo, CADirectorEdwin Kania · LOS ANGELES, CADirectorIan Leaman · El Segundo, CADirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorMark Reynoso · LOS ANGELES, CAExec · DirectorKen Deregt · New York, NYDirectorArne Brock-Utne · Lafayette, CADirectorWarren A. Heffelfinger · Lafayette, CAExec · DirectorRami Elghandour · Gaithersburg, MDDirectorDavid T. Lubner · Gaithersburg, MDDirectorAlan Young · Detroit, MIDirectorPhilip Fukushima · HONOLULU, HIDirectorCraig Brede · Englewood, CODirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗